|
1
|
Ruscito I, Dimitrova D, Vasconcelos I,
Gellhaus K, Schwachula T, Bellati F, Zeillinger R, Benedetti-Panici
P, Vergote I, Mahner S, et al: BRCA1 gene promoter methylation
status in high-grade serous ovarian cancer patients-a study of the
tumour bank ovarian cancer (TOC) and ovarian cancer diagnosis
consortium (OVCAD). Eur J Cancer. 50:2090–2098. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen J, Wang J, Zhang Y, Chen D, Yang C,
Kai C, Wang X, Shi F and Dou J: Observation of ovarian cancer stem
cell behavior and investigation of potential mechanisms of drug
resistance in three-dimensional cell culture. J Biosci Bioeng.
118:214–222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Purdie DM, Bain CJ, Siskind V, Webb PM and
Green AC: Ovulation and risk of epithelial ovarian cancer. Int J
Cancer. 104:228–232. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boyd J and Rubin SC: Hereditary ovarian
cancer: Molecular genetics and clinical implications. Gynecol
Oncol. 64:196–206. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goff BA, Mandel L, Muntz HG and Melancon
CH: Ovarian carcinoma diagnosis. Cancer. 89:2068–2075. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meunier L, Puiffe ML, Le Page C,
Lali-Mouhim A, Chevrette M, Tonin PN, Provencher DM and Mes-Masson
AM: Effect of ovarian cancer ascites on cell migration and gene
expression in an epithelial ovarian cancer in vitro model. Transl
Oncol. 3:230–238. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fishman DA, Cohen L, Blank SV, Shulman L,
Singh D, Bozorgi K, Tamura R, Timor-Tritsch I and Schwartz PE: The
role of ultrasound evaluation in the detection of early-stage
epithelial ovarian cancer. Am J Obstet Gynecol. 192:1214–1221;
discussion 1221–1222. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chobanian N and Dietrich CS III: Ovarian
cancer. Surg Clin North Am. 88:285–299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naora H and Montell DJ: Ovarian cancer
metastasis: Integrating insights from disparate model organisms.
Nat Rev Cancer. 5:355–366. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eyler CE and Rich JN: Survival of the
fittest: Cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klonisch T, Wiechec E, Hombach-Klonisch S,
Ande SR, Wesselborg S, Schulze-Osthoff K and Los M: Cancer stem
cell markers in common cancers-therapeutic implications. Trends Mol
Med. 14:450–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dexter DL, Spremulli EN, Fligiel Z,
Barbosa JA, Vogel R, VanVoorhees A and Calabresi P: Heterogeneity
of cancer cells from a single human colon carcinoma. Am J Med.
71:949–956. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Al-Hajj M and Clarke MF: Self-renewal and
solid tumor stem cells. Oncogene. 23:7274–7282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bonner WA, Hulett HR, Sweet RG and
Herzenberg LA: Fluorescence activated cell sorting. Rev Sci
Instrum. 43:404–409. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi GM, Xu Y, Fan J, Zhou J, Yang XR, Qiu
SJ, Liao Y, Wu WZ, Ji Y, Ke AW, et al: Identification of side
population cells in human hepatocellular carcinoma cell lines with
stepwise metastatic potentials. J Cancer Res Clin Oncol.
134:1155–1163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ojha R, Jha V, Singh SK and Bhattacharyya
S: Autophagy inhibition suppresses the tumorigenic potential of
cancer stem cell enriched side population in bladder cancer.
Biochim Biophys Acta. 1842:2073–2086. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yanamoto S, Kawasaki G, Yamada S,
Yoshitomi I, Kawano T, Yonezawa H, Rokutanda S, Naruse T and Umeda
M: Isolation and characterization of cancer stem-like side
population cells in human oral cancer cells. Oral Oncol.
47:855–860. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kobayashi Y, Seino K, Hosonuma S, Ohara T,
Itamochi H, Isonishi S, Kita T, Wada H, Kojo S and Kiguchi K: Side
population is increased in paclitaxel-resistant ovarian cancer cell
lines regardless of resistance to cisplatin. Gynecol Oncol.
121:390–394. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung WM, Chang WC, Chen L, Lin TY, Chen
LC, Hung YC and Ma WL: Ligand-independent androgen receptors
promote ovarian teratocarcinoma cell growth by stimulating
self-renewal of cancer stem/progenitor cells. Stem Cell Res.
13:24–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shah MM and Landen CN: Ovarian cancer stem
cells: Are they real and why are they important? Gynecol Oncol.
132:483–489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Provencher DM, Lounis H, Champoux L,
Tétrault M, Manderson EN, Wang JC, Eydoux P, Savoie R, Tonin PN and
Mes-Masson AM: Characterization of four novel epithelial ovarian
cancer cell lines. Vitro Cell Dev Biol Anim. 36:357–361. 2000.
View Article : Google Scholar
|
|
24
|
Kaur M, Ita KB, Popova IE, Parikh SJ and
Bair DA: Microneedle-assisted delivery of verapamil hydrochloride
and amlodipine besylate. Eur J Pharm Biopharm. 86:284–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lecoeur H: Nuclear apoptosis detection by
flow cytometry: Influence of endogenous endonucleases. Exp Cell
Res. 277:1–14. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prochazka L, Tesarik R and Turanek J:
Regulation of alternative splicing of CD44 in cancer. Cell Signal.
26:2234–2239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao Q, Zhang J, Liu H, Wu Q, Chen J and
Chen GQ: The mechanism of anti-osteoporosis effects of
3-hydroxybutyrate and derivatives under simulated microgravity.
Biomaterials. 35:8273–8283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Manoharan-Valerio M, Ortiz C, Quiñones J,
Feliciano G, Diaz A, Rivera D and Castro M: Determination of the
IC50 and LD50 of calcium sulfide (CaS)
clusters on malignant carcinoma and normal fibroblasts cell lines
(LB580). The FASEB Journal. 28:LB5802014.
|
|
29
|
Poff AM, Ari C, Arnold P, Seyfried TN and
D'Agostino DP: Ketone supplementation decreases tumor cell
viability and prolongs survival of mice with metastatic cancer. Int
J Cancer. 135:1711–1720. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eissing N, Heger L, Baranska A, Cesnjevar
R, Büttner-Herold M, Söder S, Hartmann A, Heidkamp GF and Dudziak
D: Easy performance of 6-color confocal immunofluorescence with
4-laser line microscopes. Immunol Lett. 161:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barber HR: Ovarian cancer. CA Cancer J
Clin. 36:149–184. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mueller H and Hahn M: Cytoreductive
surgery plus intraperitoneal hyperthermic perfusion in the
treatment of recurrent epithelial ovarian cancer: Oral Presentation
00012. Int J Gynecol Cancer. 15:542005.
|
|
33
|
Koch U, Krause M and Baumann M: Cancer
stem cells at the crossroads of current cancer therapy
failures-radiation oncology perspective. Semin Cancer Biol.
20:116–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shigdar S, Lin J, Li Y, Yang CJ, Wei M,
Zhus Y, Liu H and Duan W: Cancer stem cell targeting: The next
generation of cancer therapy and molecular imaging. Ther Deliv.
3:227–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Espinoza LA, Albanese C and Rodriguez OC:
The potential target therapy of prostate cancer stem cells.
Prostate Cancer - From Bench to Bedside. Spiess PE: InTech.
2011.
|
|
36
|
Scatena R, Bottoni P, Pontoglio A and
Giardina B: Cancer stem cells: The development of new cancer
therapeutics. Expert Opin Biol Ther. 11:875–892. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Clevers H: The cancer stem cell: Premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li XX, Wang J, Wang HL, Wang W, Yin XB, Li
QW, Chen YY and Yi J: Characterization of cancer stem-like cells
derived from a side population of a human gallbladder carcinoma
cell line, SGC-996. Biochem Biophys Res Commun. 419:728–734. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and mullerian
inhibiting substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu L, McArthur C and Jaffe RB: Ovarian
cancer stem-like side-population cells are tumourigenic and
chemoresistant. Br J Cancer. 102:1276–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Spring FA, Dalchau R, Daniels GL,
Mallinson G, Judson PA, Parsons SF, Fabre JW and Anstee DJ: The Ina
and Inb blood group antigens are located on a glycoprotein of
80,000 MW (the CDw44 glycoprotein) whose expression is influenced
by the In(Lu) gene. Immunology. 64:37–43. 1988.PubMed/NCBI
|
|
43
|
Ricardo S, Vieira AF, Gerhard R, Leitão D,
Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F and Paredes
J: Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression
distribution within intrinsic molecular subtype. J Clin Pathol.
64:937–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee CJ, Dosch J and Simeone DM: Pancreatic
cancer stem cells. J Clin Oncol. 26:2806–2812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Du L, Wang H, He L, Zhang J, Ni B, Wang X,
Jin H, Cahuzac N, Mehrpour M, Lu Y and Chen Q: CD44 is of
functional importance for colorectal cancer stem cells. Clin Cancer
Res. 14:6751–6760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Weng D, Song B, Durfee J, Sugiyama V, Wu
Z, Koido S, Calderwood SK and Gong J: Induction of cytotoxic T
lymphocytes against ovarian cancer-initiating cells. Int J Cancer.
129:1990–2001. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Au A, Aziz Baba A, Goh AS, Wahid Fadilah
SA, Teh A, Rosline H and Ankathil R: Association of genotypes and
haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with
clinical response to imatinib mesylate in chronic myeloid leukemia
patients. Biomed Pharmacother. 68:343–349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sodani K, Patel A, Anreddy N, Singh S,
Yang DH, Kathawala RJ, Kumar P, Talele TT and Chen ZS: Telatinib
reverses chemotherapeutic multidrug resistance mediated by ABCG2
efflux transporter in vitro and in vivo. Biochem Pharmacol.
89:52–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Castillo V, Valenzuela R, Huidobro C,
Contreras HR and Castellon EA: Functional characteristics of cancer
stem cells and their role in drug resistance of prostate cancer.
Int J Oncol. 45:985–994. 2014.PubMed/NCBI
|
|
51
|
Yanamoto S, Yamada S, Takahashi H, Naruse
T, Matsushita Y, Ikeda H, Shiraishi T, Seki S, Fujita S, Ikeda T,
et al: Expression of the cancer stem cell markers CD44v6 and ABCG2
in tongue cancer: Effect of neoadjuvant chemotherapy on local
recurrence. Int J Oncol. 44:1153–1162. 2014.PubMed/NCBI
|
|
52
|
El Deeb NM and Abdelzaher E: Stem cell
markers OCT4 and nestin in laryngeal squamous cell carcinoma and
their relation to survivin expression. Pathol Res Pract.
210:751–758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Krüger K, Stefansson IM, Collett K, Arnes
JB, Aas T and Akslen LA: Microvessel proliferation by co-expression
of endothelial nestin and Ki-67 is associated with a basal-like
phenotype and aggressive features in breast cancer. Breast.
22:282–288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ishiwata T, Matsuda Y and Naito Z: Nestin
in gastrointestinal and other cancers: Effects on cells and tumor
angiogenesis. World J Gastroenterol. 17:409–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wan G, Zhou L, Xie M, Chen H and Tian J:
Characterization of side population cells from laryngeal cancer
cell lines. Head Neck. 32:1302–1309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dou J, Wen P, Hu W, Li Y, Wu Y, Liu C,
Zhao F, Hu K, Wang J, Jiang C, et al: Identifying tumor stem-like
cells in mouse melanoma cell lines by analyzing the characteristics
of side population cells. Cell Biol Int. 33:807–815. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang JL, Wang Z, Hu W, Chen SS, Lou XE
and Zhou HJ: DHA regulates angiogenesis and improves the efficiency
of CDDP for the treatment of lung carcinoma. Microvasc Res.
87:14–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Fan LM and Li JM: Evaluation of methods of
detecting cell reactive oxygen species production for drug
screening and cell cycle studies. J Pharmacol Toxicol Methods.
70:40–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Matsumoto A and Nakayama KI: Role of key
regulators of the cell cycle in maintenance of hematopoietic stem
cells. Biochim Biophys Acta. 1830:2335–2344. 2013. View Article : Google Scholar : PubMed/NCBI
|
